Economic Analysis of Amifostine as Adjunctive Support for Patients with Advanced Head and Neck Cancer: Preliminary Results from a Randomized Phase II Clinical Trial from Germany

Charles L. Bennett; David Lane; Tammy Stinson; Michael Glatzel; Jens Buntzel

doi:10.1081/cnv-100000145

Economic Analysis of Amifostine as Adjunctive Support for Patients with Advanced Head and Neck Cancer: Preliminary Results from a Randomized Phase II Clinical Trial from Germany

Cancer Investigation ◽

10.1081/cnv-100000145 ◽

2001 ◽

Vol 19 (2) ◽

pp. 107-113 ◽

Cited By ~ 26

Author(s):

Charles L. Bennett ◽

David Lane ◽

Tammy Stinson ◽

Michael Glatzel ◽

Jens Buntzel

Keyword(s):

Clinical Trial ◽

Head And Neck Cancer ◽

Economic Analysis ◽

Head And Neck ◽

Phase Ii ◽

Neck Cancer ◽

Phase Ii Clinical Trial ◽

Advanced Head ◽

Preliminary Results ◽

Randomized Phase Ii

Download Full-text

Phase II clinical trial of peptide vaccination for advanced head and neck cancer patients induced immune responses and prolonged OS

Annals of Oncology ◽

10.1093/annonc/mdx376.015 ◽

2017 ◽

Vol 28 ◽

pp. v409

Author(s):

Y. Yoshitake ◽

D. Fukuma ◽

M. Hirayama ◽

H. Nakayama ◽

H. Ogi ◽

...

Keyword(s):

Clinical Trial ◽

Head And Neck Cancer ◽

Immune Responses ◽

Head And Neck ◽

Cancer Patients ◽

Phase Ii ◽

Neck Cancer ◽

Phase Ii Clinical Trial ◽

Advanced Head ◽

Peptide Vaccination

Download Full-text

Phase II clinical trial of multiple peptide vaccination for advanced head and neck cancer patients with induced immune responses and a prolonged OS.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.3094 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 3094-3094

Author(s):

Yoshihiro Yoshitake ◽

Daiki Fukuma ◽

Akira Yuno ◽

Masatoshi Hirayama ◽

Hideki Nakayama ◽

...

Keyword(s):

Clinical Trial ◽

Head And Neck Cancer ◽

Immune Responses ◽

Head And Neck ◽

Cancer Patients ◽

Phase Ii ◽

Neck Cancer ◽

Phase Ii Clinical Trial ◽

Advanced Head ◽

Peptide Vaccination

Download Full-text

Phase II Clinical Trial of Multiple Peptide Vaccination for Advanced Head and Neck Cancer Patients Revealed Induction of Immune Responses and Improved OS

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-14-0202 ◽

2014 ◽

Vol 21 (2) ◽

pp. 312-321 ◽

Cited By ~ 76

Author(s):

Yoshihiro Yoshitake ◽

Daiki Fukuma ◽

Akira Yuno ◽

Masatoshi Hirayama ◽

Hideki Nakayama ◽

...

Keyword(s):

Clinical Trial ◽

Head And Neck Cancer ◽

Immune Responses ◽

Head And Neck ◽

Cancer Patients ◽

Phase Ii ◽

Neck Cancer ◽

Phase Ii Clinical Trial ◽

Advanced Head ◽

Peptide Vaccination

Download Full-text

Adding Hyperthermia To Salvage Concurrent Chemoradiotherapy For Previously Irradiated Unresectable Recurrent Head And Neck Cancer: A Phase II Clinical Trial

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2020.07.262 ◽

2020 ◽

Vol 108 (3) ◽

pp. e790

Author(s):

K.L. Yang ◽

M.S. Chi ◽

H.L. Ko ◽

Y.Y. Huang ◽

R.H. Wu ◽

...

Keyword(s):

Clinical Trial ◽

Head And Neck Cancer ◽

Head And Neck ◽

Phase Ii ◽

Neck Cancer ◽

Concurrent Chemoradiotherapy ◽

Phase Ii Clinical Trial ◽

Recurrent Head

Download Full-text

A randomized phase II trial of cetuximab-based induction chemotherapy followed by concurrent cetuximab, 5-FU, hydroxyurea, and hyperfractionated radiation (CetuxFHX), or cetuximab, cisplatin, and accelerated radiation with concomitant boost (CetuxPX) in patients with locoregionally advanced head and neck cancer (HNC).

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.5519 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 5519-5519 ◽

Cited By ~ 11

Author(s):

T. Y. Seiwert ◽

D. J. Haraf ◽

E. E. Cohen ◽

E. A. Blair ◽

K. Stenson ◽

...

Keyword(s):

Head And Neck Cancer ◽

Head And Neck ◽

Induction Chemotherapy ◽

Phase Ii ◽

Neck Cancer ◽

Phase Ii Trial ◽

Advanced Head ◽

Randomized Phase Ii ◽

Concomitant Boost

Download Full-text

Induction chemotherapy with docetaxel/cisplatin/5-fluorouracil followed by randomization to two cisplatin-based concomitant chemoradiotherapy schedules in patients with locally advanced head and neck cancer (CONDOR study) (Dutch Head and Neck Society 08-01): A randomized phase II study

European Journal of Cancer ◽

10.1016/j.ejca.2015.09.024 ◽

2016 ◽

Vol 52 ◽

pp. 77-84 ◽

Cited By ~ 23

Author(s):

C.M.L. Driessen ◽

J.P. de Boer ◽

H. Gelderblom ◽

C.R.N. Rasch ◽

M.A. de Jong ◽

...

Keyword(s):

Head And Neck Cancer ◽

Head And Neck ◽

Induction Chemotherapy ◽

Phase Ii ◽

Neck Cancer ◽

Phase Ii Study ◽

Locally Advanced ◽

Advanced Head ◽

Concomitant Chemoradiotherapy ◽

Randomized Phase Ii

Download Full-text

Phase II clinical trial of suberoylanilide hydroxamic acid (SAHA) in patients (pts) with recurrent and/or metastatic head and neck cancer(SCCHN)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.5578 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 5578-5578

Author(s):

G. Blumenschein ◽

C. Lu ◽

M. Kies ◽

B. Glisson ◽

V. Papadimitrakopoulou ◽

...

Keyword(s):

Clinical Trial ◽

Head And Neck Cancer ◽

Head And Neck ◽

Phase Ii ◽

Neck Cancer ◽

Hydroxamic Acid ◽

Phase Ii Clinical Trial ◽

Suberoylanilide Hydroxamic Acid

Download Full-text

832 Poster Subcutaneous amifostine. Does it reduce the acute toxicity of a concomitant chemoradiation scheme in advanced head and neck cancer? Preliminary results of a randomized clinical trial

Radiotherapy and Oncology ◽

10.1016/s0167-8140(02)83141-3 ◽

2002 ◽

Vol 64 ◽

pp. S247

Keyword(s):

Clinical Trial ◽

Head And Neck Cancer ◽

Acute Toxicity ◽

Head And Neck ◽

Randomized Clinical Trial ◽

Neck Cancer ◽

Advanced Head ◽

Preliminary Results ◽

Concomitant Chemoradiation

Download Full-text

Consolidation cetuximab after concurrent triplet radiochemotherapy+cetuximab in patients with advanced head and neck cancer: A randomized phase II study

Radiotherapy and Oncology ◽

10.1016/j.radonc.2020.06.011 ◽

2020 ◽

Vol 150 ◽

pp. 62-69

Author(s):

Oliver Riesterer ◽

Martin Pruschy ◽

Sabine Bender ◽

Ashish Sharma ◽

Marta Bogowicz ◽

...

Keyword(s):

Head And Neck Cancer ◽

Head And Neck ◽

Phase Ii ◽

Neck Cancer ◽

Phase Ii Study ◽

Advanced Head ◽

Randomized Phase Ii

Download Full-text

392 Randomized Phase II study of weekly cisplatin with or without amifostine in patients with advanced head and neck cancer

European Journal of Cancer ◽

10.1016/0959-8049(95)95645-m ◽

1995 ◽

Vol 31 ◽

pp. S85-S86

Author(s):

A.S.T. Planting ◽

J.B. Vermorken ◽

G. Catimel ◽

P.H.M. de Mulder ◽

A. de Graeff ◽

...

Keyword(s):

Head And Neck Cancer ◽

Head And Neck ◽

Phase Ii ◽

Neck Cancer ◽

Phase Ii Study ◽

Advanced Head ◽

Randomized Phase Ii ◽

Weekly Cisplatin

Download Full-text